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Departament de Gene`tica, Facultat de Biologia, Universitat de Barcelona, Barcelona
Retinitis pigmentosa (RP), the main cause of adult blindness, is a genetically heterogeneous disorder characterized
by progressive loss of photoreceptors through apoptosis. Up to now, 39 genes and loci have been implicated in
nonsyndromic RP, yet the genetic bases of 150% of the cases, particularly of the recessive forms, remain unknown.
Previous linkage analysis in a Spanish consanguineous family allowed us to deﬁne a novel autosomal recessive RP
(arRP) locus, RP26, within an 11-cM interval (17.4 Mb) on 2q31.2-q32.3. In the present study, we further reﬁne
the RP26 locus down to 2.5 Mb, by microsatellite and single-nucleotide polymorphism (SNP) homozygosity map-
ping. After unsuccessful mutational analysis of the nine genes initially reported in this region, a detailed gene search
based on expressed-sequence-tag data was undertaken. We ﬁnally identiﬁed a novel gene encoding a ceramide kinase
(CERKL), which encompassed 13 exons. All of the patients from the RP26 family bear a homozygous mutation
in exon 5, which generates a premature termination codon. The same mutation was also characterized in another,
unrelated, Spanish pedigree with arRP. Human CERKL is expressed in the retina, among other adult and fetal
tissues. A more detailed analysis by in situ hybridization on adult murine retina sections shows expression of Cerkl
in the ganglion cell layer. Ceramide kinases convert the sphingolipid metabolite ceramide into ceramide-1-phosphate,
both key mediators of cellular apoptosis and survival. Ceramide metabolism plays an essential role in the viability
of neuronal cells, the membranes of which are particularly rich in sphingolipids. Therefore, CERKL deﬁciency
could shift the relative levels of the signaling sphingolipid metabolites and increase sensitivity of photoreceptor and
other retinal cells to apoptotic stimuli. This is the ﬁrst genetic report suggesting a direct link between retinal
neurodegeneration in RP and sphingolipid-mediated apoptosis.
Introduction
Inherited retinal degenerative diseases are characterized
by the progressive loss of mature photoreceptor cells
through apoptosis. Among them, retinitis pigmentosa
(RP [MIM 268000]), the most common hereditary cause
of blindness, comprises a clinically and genetically het-
erogeneous group of retinal disorders that affects ∼1.5
million people worldwide (Sullivan and Daiger 1996).
Patients with RP typically show night blindness, gradual
visual impairment, and bone spicule–like pigment de-
posits in the retina.
RP is a paradigm of monogenic diseases with ex-
tremely high genetic heterogeneity (Hims et al. 2003).
This complexity has clearly hindered the identiﬁcation
of causative genes, particularly in the recessive forms,
since large nuclear families suitable for linkage studies
are scarce. In fact, although 39 genes and loci have been
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described, many others, still unknown, could account
for the remaining unassigned cases. At present, the re-
ported RP causative genes fall into four categories: (a)
genes directly involved in the phototransduction cas-
cade, (b) genes encoding proteins responsible for the
structure and polarity of the photoreceptors, (c) genes
encoding proteins of the visual cycle, and (d) regulatory
genes (such as transcription and splicing factors). In the
study of autosomal recessive RP (arRP), mutations on
16 genes and linkage to ﬁve chromosomal regions have
been reported (Wang et al. 2001; RetNet Web site).
Therefore, RP gene identiﬁcation is still a priority in this
ﬁeld, since it not only is needed for diagnosis but also
is crucial for giving insights into the molecular basis of
the disease.
RP26, one of the remaining uncharacterized loci, was
previously mapped to an 11-cM interval on 2q31.2-q32
in a consanguineous family with arRP (Baye´s et al. 1998).
Later, this 11-cM interval, between markers D2S148 and
D2S117, was ascribed to a physical distance of 17.4 Mb
that comprised more than 50 genes. As the incoming
human genome data were made available in the pub-
lic databases, new markers—either microsatellites or,
mainly, SNPs—were retrieved and analyzed, ﬁrst for co-
segregation and ﬁnally for homozygosity mapping. All
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of this new information allowed us to narrow the can-
didate region to 2.5 Mb, and mutational screening was
subsequently performed to identify the RP26 gene.
Material and Methods
Families and DNA
The two families with arRP we analyzed, P2 and E1,
have been described elsewhere (Baye´s et al. 1996, 1998).
Blood samples were collected from family members, and
DNA was extracted using a commercial kit (Wizard Ge-
nomic DNA Puriﬁcation Kit [Promega]). Informed con-
sent was gathered from all family members. This re-
search followed the tenets of the Declaration ofHelsinki.
Cosegregation and Homozygosity Mapping
The RP26 locus was further reﬁned using three ﬂank-
ing markers: D2S2978, D2S2261, and D2S273 (table
1). For subsequent homozygosity mapping, additional
markers (13 microsatellites and 101 SNPs) were chosen
on the basis of their physical position according to the
National Center for Biotechnology Information (NCBI)
Human Builds 29–33 at the University of California
Santa Cruz Genome Bioinformatics Web site (table 1).
The SNP sequences were retrieved from the NCBI
dbSNP Home Page and The SNP Consortium database.
New SNPs observed during this study were submitted
and deposited in the NCBI dbSNP database (see table
1). SNP analyses involved PCR assays with ﬂanking
primers and subsequent sequencing to verify the geno-
type. Three ampliﬁcation steps (30 s each), with the an-
nealing temperature ranging from 48C to 61C, were
performed. The reaction mixture (50 ml) contained 10
mM of each primer, 2 mM of dNTPs, 1.5 mM MgCl2,
and 1 U of Taq polymerase (Innogenetics).
Mutation Screening
Primers located at the ﬂanking intron regions were de-
signed to amplify each coding exon for all the analyzed
genes in all samples. Three ampliﬁcation steps (30 s each),
with the annealing temperature ranging from 45C to
60C, were performed. Sequencing was performed using
the BigDye Terminator Cycle Sequencing v3.1 kit and the
automatic sequencers ABI 3700 and ABI 3730 (Applied
Biosystems).
Mutation Restriction Analysis
A forward primer (5′-GAAGAATGCTGGGATGGA-
AACGGAC-3′) containing a mismatch nucleotide (un-
derlined) that created anAvaII restriction site in the exon
5 wild-type sequence was designed. A three-step PCR
(annealing temperature 50C) was performed on the ge-
nomic DNA of the P2 and E1 family members, through
use of the mismatch forward primer and exon 5 reverse
primer (5′-GTTGTGCTGTCTAGATTAGC-3′), under
the conditions mentioned above. The 157-bp PCR frag-
ments were digested with AvaII and were resolved in a
4% low-melting-temperature agarose gel.
Human and Murine CERKL cDNA Characterization
Database searches from the available human genomic
sequence allowed the identiﬁcation of a truncated EST
(GenBank accession number BE797822) and a partial
cDNA (GenBank accession number BC020465), which
overlapped 18 bp. To characterize the full-length cDNA,
a human retina cDNA library (BD Biosciences) was
screened ( plaque-forming units) with a mix-61.2# 10
ture of all the CERKL coding exons as a probe. The
hybridization was performed overnight under highly
stringent conditions (42C in 50% formamide, 5#Den-
hardt’s, 5# SSPE, 0.1% sodium dodecyl sulfate, and
100 mg/ml salmon spermDNA), and several washeswere
performed at 55C in 2# SSC and 1# SSC before au-
toradiography. Only a partial CERKL cDNA was ob-
tained. For the full-length coding sequence, we devised
a PCR strategy using two speciﬁc primers ﬂanking the
conceptual ATG and STOP codons on the Marathon-
Ready retina cDNA (BD Biosciences) under the follow-
ing conditions: 94C for 30 s, 60C for 30 s, and 72C
for 2 min for 40 cycles. The reaction mixture (50 ml)
contained 10 mM of each primer, 2 mM of dNTPs, 1.5
mM MgCl2, 1 U of Taq polymerase (Innogenetics), and
5% DMSO.
TBLASTN database searches at the NCBI BLAST
server revealed two murine sequences homologous to
human CERKL, one EST (GenBank accession number
BY742285) and one partial cDNA (GenBank accession
number BC046474), which had 377 nt of overlap with
one another. Protein alignment was performed with
CLUSTALW 1.8 at the BCM Search Launcher Web site
and was depicted with BOXSHADE 3.21 at the EMBnet
BoxShade Server.
Phylogenetic Analysis
Protein sequences from several members of the diacyl-
glycerol, sphingosine, and ceramide kinase families were
retrieved from public databases and aligned with human
and murine CERKL through use of CLUSTALX version
1.64 (Thompson et al. 1997). The resulting phylogenetic
tree was constructed using the neighbor-joining algorithm
and considering the diacylglycerol kinase sequences as
outgroup.
RT-PCRs
Two speciﬁc primers on exons 8 (5′-CCATTTAACA-




Microsatellite and SNP Markers Analyzed on 2q31.2-q32.3
Microsatellite or SNP IDa Locationb Locus
Genotype in
RP26 Patientsc
D2S148; AFM200WA11 chr2: 176902551–176902745 Recombinant
D2S2978; ATA44H04 chr2: 179788236–179788348 Recombinant
D2S2261; AFMB072WG1 chr2: 180180111–180180442 Recombinant
rs1002207; TSC0036660 chr2: 180237706 Noninformative
rs1949453; TSC1026876 chr2: 180594170 UBE2E3 Homozygous
*rs2077783; TSC0046543 chr2: 180834855 Homozygous
*rs720453; TSC0046544 chr2: 180834909 Homozygous
*D2S2310; AFMB355XD5 chr2: 180849531–180849858 Noninformative
*rs155100; TSC0531809 chr2: 181033165 ITGA4 Homozygous
*rs155101; TSC0531810 chr2: 181033223 ITGA4 Homozygous
*rs155102 chr2: 181033525 ITGA4 Homozygous
*rs155103 chr2: 181033821 ITGA4 Homozygous
rs1801262 chr2: 181226533 NEUROD1 Homozygous
rs2583016 chr2: 181228296 NEUROD1 Homozygous
*rs1157595; TSC0326375 chr2: 181432646 Homozygous
*D2S364; AFM303YA9 chr2: 181717611–181718002 PDE1A Homozygous
*rs3754929 chr2: 181771662 PDE1A Homozygous
*rs1438065; TSC0655111 chr2: 181902071 PDE1A Homozygous
*rs833152; TSC0655110 chr2: 181902179 PDE1A Noninformative
rs288254; TSC0681111 chr2: 182291705 ERdj5 Noninformative
rs7510 chr2: 182472727 NCKAP1 Heterozygous
ss12676100 chr2: 182476461 NCKAP1 Heterozygous
ss12676101 chr2: 182476476 NCKAP1 Heterozygous
ss12676102 chr2: 182482636 NCKAP1 Heterozygous
rs2271671 chr2: 182510096 NCKAP1 Heterozygous
D2S350; AFM292WD1 chr2: 182532022–182532389 NCKAP1 Heterozygous
ss12676103 chr2: 182678153 LOC129401 Heterozygous
ss12676104 chr2: 182678197 LOC129401 Heterozygous
ss12676105 chr2: 182678220 LOC129401 Heterozygous
D2S2273; AFMB297XC1 chr2: 182825486–182825797 Heterozygous
D2S2281; AFMB310XF5 chr2: 182863973–182864335 Heterozygous
D2S2366; AFMA057VG9 chr2: 183175061–183175459 Noninformative
rs826135; TSC1254035 chr2: 183459257 Noninformative
rs826134; TSC0476562 chr2: 183459267 Noninformative
ss12676106 chr2: 183459509 Heterozygous
rs826133; TSC0658245 chr2: 183459526 Noninformative
ss12676107 chr2: 183459659 Heterozygous
ss12676108 chr2: 183459776 Heterozygous
rs826132; TSC0658244 chr2: 183459802 Heterozygous
D2S1391; GATA65C03 chr2: 183675508–183675835 Homozygous
rs1443021; TSC0664031 chr2: 183910062 Heterozygous
rs1443022; TSC0664032 chr2: 183910149 Heterozygous
rs768352; TSC0076040 chr2: 184012769 Homozygous
rs994653; TSC0317578 chr2: 184193063 Homozygous
rs728534; TSC0064305 chr2: 184484995 Homozygous
rs3046266; TSC1530131 chr2: 184485293 Noninformative
rs1366842; TSC0514415 chr2: 184485321 Noninformative
rs3731834 chr2: 184486442 Homozygous
D2S1361; GATA14E05 chr2: 184899775–184900087 Heterozygous
rs1016410; TSC0098979 chr2: 185334459 Heterozygous
rs1019430; TSC0223209 chr2: 185334589 Heterozygous
rs878845; TSC0212635 chr2: 185580725 Heterozygous
ss12676109 chr2: 186138356 ITGAV Heterozygous
ss12676110 chr2: 186170238 ITGAV Heterozygous
ss12676111 chr2: 186181185 ITGAV Heterozygous
ss12676112 chr2: 186186304 ITGAV Heterozygous
ss12676113 chr2: 186202416 ITGAV Heterozygous
rs3816386 chr2: 186211713 ITGAV Heterozygous
rs2018302; TSC0091486 chr2: 186467891 Heterozygous
rs1467990; TSC0384843 chr2: 186468012 Noninformative
rs2018314; TSC0085681 chr2: 186468088 Heterozygous
rs1000623; TSC0033486 chr2: 186468142 Heterozygous
rs840570; TSC1028023 chr2: 186855755 Noninformative
rs2308091 chr2: 186856059 Noninformative
rs84069 chr2: 186856203 Noninformative




Microsatellite or SNP IDa Locationb Locus
Genotype in
RP26 Patientsc
D2S152; AFM207XG1 chr2: 186914674–186915071 CALCRL Noninformative
rs1398061; TSC0576737 chr2: 186941063 CALCRL Noninformative
rs1464338; TSC0378776 chr2: 187177069 Noninformative
rs1464337; TSC0378775 chr2: 187177070 Noninformative
rs2176858; TSC1217605 chr2: 187177146 Noninformative
rs2033838; TSC1047282 chr2: 187551834 Heterozygous
rs2028374; TSC1091521 chr2: 187666577 Heterozygous
rs1354906; TSC0490640 chr2: 188129892 CED-6 Homozygous
rs1007120: TSC0084553 chr2: 188175289 Noninformative
rs925825; TSC0241755 chr2: 188431720 Heterozygous
rs893407; TSC0165376 chr2: 189033193 Heterozygous
rs2289404 chr2: 189318673 ORMDL1 Noninformative
rs6942; TSC0023616 chr2: 189319070 ORMDL1 Homozygous
rs3791767 chr2: 189322574 ORMDL1 Noninformative
rs288817; TSC1078112 chr2: 189529648 Noninformative
ss12676114 chr2: 189529690 Homozygous
rs998173; TSC0011271 chr2: 189694293 Homozygous
rs3791789 chr2: 189787488 HIBCH Heterozygous
D2S2262; AFMB082YE1 chr2: 189985176–189985493 Heterozygous
rs7721 chr2: 190069246 Heterozygous
rs1128723 chr2: 190069374 Heterozygous
rs8962 chr2: 190074316 Noninformative
rs1468685; TSC0385949 chr2: 190268436 Heterozygous
rs1263136; TSC1488116 chr2: 190298357 Noninformative
rs1263125; TSC0446273 chr2: 190303089 Homozygous
D2S118; AFM066XC1 chr2: 190309134–190309312 Homozygous
rs1263100; TSC0398872 chr2: 190327138 Heterozygous
rs1476896; TSC0398871 chr2: 190327184 Homozygous
D2S389; AFM333WF9 chr2: 190347305–190347628 Homozygous
rs1882395; TSC0896111 chr2: 190387668 Homozygous
D2S1775; GATA71C07 chr2: 190402485–190402614 Homozygous
rs3217036 chr2: 190462343 GLS Noninformative
rs2355571 chr2: 190477428 GLS Heterozygous
rs2883713 chr2: 190491082 GLS Heterozygous
rs3199237 chr2: 190497863 GLS Noninformative
rs3207595 chr2: 190497884 GLS Noninformative
rs3207596 chr2: 190497887 GLS Noninformative
rs3199238 chr2: 190497893 GLS Noninformative
rs3207597 chr2: 190497917 GLS Noninformative
rs1801893 chr2: 190498994 GLS Noninformative
rs3215259 chr2: 190521768 GLS Noninformative
rs1058589 chr2: 190522002 GLS Noninformative
rs1058590 chr2: 190522011 GLS Noninformative
rs1058591 chr2: 190522017 GLS Noninformative
rs1058592 chr2: 190522020 GLS Noninformative
rs1547550; TSC0429185 chr2: 190548390 STAT1 Heterozygous
rs925847; TSC0241788 chr2: 190600205 STAT4 Noninformative
rs3024891 chr2: 190601614 STAT4 Heterozygous
D2S2246; AFMB007WC1 chr2: 191085514–191085746 Heterozygous
D2S318; AFM105XC1 chr2: 191278428–191278834 Homozygous
D2S161; AFM224ZF4 chr2: 191431730–191432052 Heterozygous
D2S280; AFM155YE1 chr2: 191557728–191557932 TMEFF2 Homozygous
rs3738882 chr2: 191751560 TMEFF2 Homozygous
rs935367; TSC0352562 chr2: 191842107 Noninformative
D2S315; AFM081YG5 chr2: 192076101–192076267 Homozygous
rs717621; TSC0040380 chr2: 192153621 Heterozygous
D2S273; UT5048 chr2: 192288946–192289538 Recombinant
D2S117; AFM065YF11 chr2: 194331362–194331699 Recombinant
a Microsatellite IDs are those that begin with “D,” and SNP IDs are those that begin with “rs” or “ss.” SNPs IDs that
begin with “ss” are those identiﬁed in the present study and are deposited in the NCBI dbSNP database. Microsatellite and
SNP IDs preceded by an asterisk (*) are the ﬂanking CERKL markers used for haplotype analysis and comparison in families
P2 and E1.
b Location in NCBI Build 32.
c Boldface italic type indicates candidate homozygous region.
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Figure 1 The RP26 locus and the CERKL gene and protein. A, RP26 physical map of the 12.5-Mb cosegregation interval betweenmarkers
D2S2261 and D2S273. B, Localization of CERKL within the candidate region (“CR”) deﬁned by homozygosity mapping. Genes (rectangles)
and the transcription direction (arrowheads) are indicated. C, CERKL exon/intron structure. The location of the R275X null mutation in exon
5 is shown.
ﬁed 429 bp, were used to detect CERKL expression on
a panel of ﬁrst-strand cDNAs of several human adult
and fetal tissues (BD Biosciences). Speciﬁc CERKL ex-
pression was conﬁrmed by sequencing the ampliﬁed
products. Ampliﬁcation of GAPD was used to compare
and normalize the samples, as suggested by the manu-
facturer. PCR conditions were as follows: 35 cycles of
94C for 30 s and 65C for 60 s. The reaction mixture
(50 ml) contained 10 mM of each primer, 2 mMof dNTPs,
1.5 mM MgCl2, and 1 U Taq pol (Innogenetics).
In Situ Hybridizations
For in situ hybridization, adult mouse eye slides from
the C57BL/6J strain were obtained from Novagen. Eyes
were ﬁxed in 4% paraformaldehyde, embedded in par-
afﬁn, and sectioned at 7 mm. Sections were washed for 7
min three times with xylene to remove parafﬁn, for 3 min
twice with ethanol 100%, for 3 min with ethanol 90%,
for 3 min with ethanol 70%, and for 3 min with diethyl
pyrocarbonate–treated water, and then were ﬁxed with
4% paraformaldehyde for 20 min. Sections were treated
with 2 mg/ml proteinase K for 30 min, washed for 5 min
twice with phosphate-buffered saline, and postﬁxed with
4% paraformaldehyde. Acetylation with 0.1 M trietha-
nolamine-HCl (pH 8.0) containing 0.25% acetic anhy-
dride was performed for 10 min. Slides were subsequently
washed, ethanol dehydrated, and air dried. Hybridization
was performed overnight at 55C with 2 mg/ml digoxi-
genin-labeled riboprobes in 50% formamide, 1 # Den-
hardt’s solution, 10% dextran sulfate, 0.3 M NaCl, 10
mM Tris-HCl (pH 8.0), 5 mM EDTA (pH 8.0), 10 mM
NaH2PO4, and 200 mg/ml salmon sperm DNA.
The riboprobes were generated from the T7 and T3
promoters of a pBluescript II KS vector containing either
a 201-bp HindIII-PstI fragment, a 350-bp HindIII frag-
ment, a 513-bp PstI-SphI fragment of the murine Cerkl
cDNA IMAGE 4504238, or a 198-bp fragment from
coding exon 4 of murine rhodopsin.
After hybridization, the slides were washed in 2# SSC
for 20 min; washed for 5 min twice in a solution of 50%
formamide and 2# SSC (washes at 50C); equilibrated
in NTE (0.5 M NaCl, 10 mM Tris-HCl pH 8.0, 5 mM
EDTA) at 37C; and then treated with 10 mg/ml RNase
A in NTE at 37C for 30 min. Subsequently, the sections
were washed in NTE, 2# SSC, and 0.1# SSC (15 min
each), equilibrated in buffer 1 (100 mM Tris-HCl pH
7.5, 150 mMNaCl), and blocked in blocking buffer (1%
BSA and 0.1% Triton X-100 in buffer 1) for 30 min.
An anti-digoxigenin-AP conjugate antibody (1:500;
Roche Applied Science) in blocking buffer was incubated
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Figure 2 Protein alignment of human (“h”) and murine (“m”) CERKL and CERK. Identical residues are highlighted in black, and
conservative positions are in gray. The solid black line underlines the conserved COG1597 (LCB5) domain detected after comparison with the
NCBI Conserved Domain Database. Murine CERKL sequence was assembled from GenBank sequences BY742285 and BC046474, human
CERK sequence from AB079066, and murine CERK sequence from AB79067.
overnight at 4C. The sections were washed twice in
buffer 1 for 15 min and in buffer 2 (100 mM Tris-HCl
pH 9.5, 150 mM NaCl, and 50 mM MgCl2) for 10 min
prior to exposure to the alkaline phosphatase substrate,
nitroblue tetrazolium–5-bromo-4-chloro-3-indoyl phos-
phate (NBT-BCIP; Roche Applied Science). The reaction
was stopped by several washes in distilled water. The
sections were cover-slipped with 70% glycerol in PBS
and were photographed using a Nomarski optics mi-
croscope (Axioplan, Carl Zeiss) equipped with a Nikon
Coolpix digital camera.
Results
Reﬁnement of the Cosegregation Region
and Candidate Gene Analysis
The analysis of two proximal (D2S2978 andD2S2261)
and one distal (D2S273) ﬂanking markers (table 1) al-
lowed further reﬁnement of the RP26 locus to a 12.5-Mb
interval (ﬁg. 1A). As a ﬁrst attempt to identify the caus-
ative gene, a mutational screening of candidate genes se-
lected on the basis of their known retinal function or the
phenotype of Drosophila mutants or knockout mice was
performed. The analysis of ﬁve candidates (ORMDL1,
ITGAV, GLS, NEUROD1, and FRZB) within this inter-
val did not reveal any pathogenic mutation.
Homozygosity Mapping and Mutation Screening
The reported consanguinity of the RP26 family and
the availability of new markers after the sequencing of
the human genome made homozygosity mapping fea-
sible as a means to reduce the candidate region. Sixteen
microsatellite markers and 101 SNPs located within the
12.5-Mb interval (table 1) were analyzed in all P2 fam-
ily members. Eventually, only one homozygous segment
spanning 11 Mb, between markers D2S2261 and
D2S350 (ﬁg. 1A), was identiﬁed. This candidate region,
spanning 2.5 Mb, harbored ﬁve annotated genes and
four partially characterized mRNAs (ﬁg. 1B), which
were prioritized for mutational analysis on the basis of
(a) retinal expression, as assessed by PCR on a retina
cDNA library; and (b) availability of functional data.
All of them were eventually sequenced (in fact, two
genes, NEUROD1 and FRZB, were analyzed in the pre-
vious section), but none showed any pathogenic variant.
Identiﬁcation of a Novel Gene, CERKL
A more exhaustive database search for uncharacterized
cDNAs and spliced ESTs within the candidate 2.5-Mb
region was undertaken and revealed two close sequences,
one EST (GenBank accession number BE797822) and one
eye/retinoblastoma incomplete cDNA (GenBank acces-
sion number BC020465), located between the ITGA4 and
the NEUROD1 genes. The conceptual protein from the
in silico assembly of both sequences showed homology
with eukaryotic ceramide, sphingosine, and diacylglycerol
kinases and strongly suggested that the sequences ana-
lyzed corresponded to a novel, unreported gene. After
screening a human retina cDNA library and performing
serial PCR assays on retina cDNA, we obtained the full-
length 1,596-nt coding sequence, which spanned 13 exons
(ﬁg. 1C). The predicted 532-aa protein showed the highest
similarity (29% identity; 50% similarity) with the human
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Figure 3 Unrooted phylogenetic tree of several members of the diacylglycerol, sphingosine, and ceramide kinases, including the human
and murine CERKL sequences described in the present study (boxed). The tree was obtained with the neighbor-joining algorithm of the program
ClustalX version 1.64b. Numbers show the values for the bootstrap analysis. SPHKs p sphingosine kinases; CERKsp ceramide kinases; and
DGKs p diacylglycerol kinases. Abbreviations and GenBank accession numbers are as follows: human sphingosine kinase 1 (hSPHK1),
AAF73423; murine sphingosine kinase 1 (mSPHK1), AAC61697; human sphingosine kinase 2 (hSPHK2), AAF74124; murine sphingosine kinase
2 (mSPHK2), AAF74125; Drosophila sphingosine kinase (dSPHK), AAF48045; Ciona intestinalis sphingosine kinase (ciSPHK), AK112588;
yeast sphingosine kinase Lcb4 (Lcb4p), NP_014814; yeast sphingosine kinase Lcb5 (Lcb5p), NP_013361; Arabidopsis thaliana sphingosine
kinase (AtSPHK), AY128394; human ceramide kinase (hCERK), AB079066; murine ceramide kinase (mCERK), AB079067; Ciona intestinalis
ceramide kinase (ciCERK), AK112750; Drosophila ceramide kinase (dCERK), AAF52040; human ceramide kinase-like (hCERKL), AY357073;
murine ceramide kinase-like (mCERKL), BY742285 and BC046474; Caenorhabditis elegans ceramide kinase (cCERK), AAC67466; human
diacylglycerol kinase b subunit (hDGKb), Q9Y6T7; murine diacylglycerol kinase b subunit (mDGKb), XP_147651; human diacylglycerol kinase
epsilon subunit (hDGKe), NP_003638; murine diacylglycerol kinase epsilon subunit (mDGKe), NP_062378); Caenorhabditis elegans diacyl-
glycerol kinase 1 (cDGK1), NP_508190; Arabidopsis thaliana diacylglycerol kinase 1 (AtDGK1), Q39017; Drosophila diacylglycerol kinase 2
(dDGK2), Q09103; and Drosophila diacylglycerol kinase 1 (dDGK1), Q01583.
ceramide kinase (CERK [Sugiura et al. 2002]) (ﬁg. 2) and,
therefore, the gene was named “human ceramide kinase–
like” (CERKL [HUGO-approved nomenclature]). In
addition, database searches revealed one murine EST
(GenBank accession number BY742285) and one partial
cDNA (GenBank accession number BC046474), which,
upon assembly and conceptual translation, produced a
protein that was highly homologous to human CERKL
(75% identity; 85.6% similarity) (ﬁg. 2). To verify that
CERKL belonged to the ceramide kinase subfamily of
lipid kinases, a phylogenetic tree was constructed using
24 protein sequences from different eukaryotic phyla.
Human and murine CERKL sequences clearly clustered
within the branch of ceramide kinases (ﬁg. 3).
Premature Truncation of CERKL Causes arRP
The CERKL coding exons were sequenced in all mem-
bers of the RP26 family. All patients were homozygous
for a nonsense mutation (R257X; CGArTGA) in exon
5, which prematurely truncates the protein within the
predicted catalytic domain (ﬁg. 4A and 4B). This mu-
tation was not observed in 170 unrelated, ethnically
matched control individuals. We subsequently evaluated
cosegregation of RP with two CERKL ﬂanking markers
(D2S2310 and D2S364) in a panel of small nuclear
Spanish families with RP whose causative gene was still
unknown. An additional cosegregating pedigree, unre-
lated to the RP26 family, was identiﬁed. The CERKL
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Figure 4 A, DNA sequence of exon 5 in an unaffected individual and patient VI.15 of the P2 family, showing the homozygous nonsense
R257X mutation. B, Pedigrees of P2 and E1 families, showing the ARMS analysis of R257X mutation. A speciﬁc primer was designed to
generate an AvaII restriction site in the ampliﬁed wild-type allele. All RP-affected individuals are homozygous for the mutant, nonrestricted
allele. Individuals whose DNA samples were not available are indicated by a number sign (#).
sequence analysis showed that the affected members
were also homozygous for the R257Xmutation (ﬁg. 4B),
thus reinforcing the pathogenicity of this CERKL vari-
ant. Although both families share the same mutation,
the haplotype analysis of the 12 nearest ﬂankingmarkers
(see table 1), stretching 600 kb around CERKL, does
not support a common ancestry (data not shown).
CERKL Shows a Tissue-Speciﬁc Pattern of Expression
Northern expression analysis of CERKL did not re-
veal any transcript on two panels of several human tis-
sues, even after long exposure times (data not shown).
This suggested either speciﬁc expression in nontested tis-
sues or very low transcriptional levels, in contrast to the
higher and more ubiquitous expression of the CERK
gene (Sugiura et al. 2002). The more sensitive RT-PCR
assays revealed moderate expression in adult human ret-
ina, kidney, lung, and pancreas, and low levels in brain,
placenta, and liver (ﬁg. 5). The RT-PCRs on human fetal
tissues also showed expression in lung, kidney, and brain
(ﬁg. 5).
To assess CERKL expression in the retina more ac-
curately, we performed in situ hybridization on mouse
eye sections. The mouse CERKL ortholog is predomi-
nantly expressed in the retina ganglion cell layer, al-
though a faint signal is also detected in the inner nuclear
and photoreceptor cell layers (ﬁg. 6A and 6B). The axons
from the ganglion cells merge in the optic nerve and,
therefore, constitute the last cellular component of pho-
totransduction in the retina.
As a positive control, we assayed rhodopsin, which is
highly expressed in the photoreceptor cells (ﬁg. 6C). It
is remarkable that, at a comparable speciﬁc labeling and
concentration probe, rhodopsin hybridization signalwas
much more intense and was detected much earlier than
Cerkl expression, again supporting the low transcrip-
tional levels of the latter.
Discussion
The identiﬁcation of CERKL and its characterization as
an RP causative gene opens new avenues for evaluating
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Figure 5 CERKL and GAPD (control) RT-PCR expression analysis on several human tissues, including retina
Figure 6 A, Cerkl in situ hybridization on murine eye sections
with the antisense riboprobe. B, Cerkl in situ hybridization on murine
eye sections with the sense riboprobe (negative control).C, Rhodopsin
in situ hybridization on murine eye sections (positive control). RPEp
retinal pigment epithelium; PhR p photoreceptor cell layer; ONLp
outer nuclear layer; OPLp outer plexiform layer; INLp inner nuclear
layer; IPL p inner plexiform layer; GCL p ganglion cell layer.
its contribution—as well as that of other sphingolipid
(SL) metabolism enzymes—to retinal function and dis-
ease. The pathogenicity of the R257X mutation is sup-
ported not only by the absence of this variant in the
control population (the test on 340 chromosomes allows
the detection of a polymorphism of 1% with 95% sta-
tistical conﬁdence [Collins and Schwartz 2002]) but also,
and with more relevance to function, by the premature
truncation of the protein (position 257 out of 532 aa),
well within the strictly conserved catalytic domain of
ceramide, sphingosine, and diacylglycerol kinases (ﬁg.
2).
During the last decade and after exhaustive cosegre-
gation analyses using internal and ﬂanking markers of
all the reported arRP genes and loci (including RP26),
we have identiﬁed the causative gene in only 8 (∼15%)
families out of 52 Spanish pedigrees with arRP. When
we consider all our data, CERKL (responsible for the
disease in two families [present study]) appears to con-
tribute to arRP to a similar extent as other well-known
arRP genes, such as PDE6B (three families [Baye´s et
al. 1996]), TULP1 (one family [Paloma et al. 2000]),
ABCA4 (one family [Martı´nez-Mir et al. 1998]), and
CNGA1 (one family [Paloma et al. 2002]). Although it
is too early to assess the real contribution of CERKL
to retinal disorders, we surmise that, after this ﬁrst
study, additional families and new mutations will be
readily described.
When we consider CERKL function, we should re-
member that SLs are structural membrane components,
particularly abundant in neurons. SL accumulation is as-
sociated with severe neurodegenerative disorders (Gau-
cher, Tay-Sachs, and Niemann-Pick A and B diseases
[Buccoliero and Futerman 2003]). Moreover, increasing
evidence points to both nonphosphorylated and phos-
phorylated sphingosine and ceramide as essential second
messengers in cellular stress, senescence, growth, and ap-
optosis (Luberto et al. 2002). SLs and their metabolic
products act as biosensors of the cellular state, and the
enzymes that regulate SL metabolism appear to be ﬁne-
tuned cellular switches, connecting several pathwayswith
antagonistic properties (Hannun andObeid 2002). Thus,
ceramide and sphingosine lead to cell growth arrest and
apoptosis, whereas sphingosine-1-phosphate and cer-
amide-1-phosphate have antiapoptotic and neuroprotec-
tive effects (Frago et al. 1998, 2003; Hannun and Obeid
2002; Spiegel and Milstien 2002, 2003). In this context,
sensory neuropathies (hereditary sensory neuropathy
type 1 [Dawkins et al. 2001]) and other neurodegener-
ative diseases (Batten disease [Puranam et al. 1999]) have
recently been associated with ceramide metabolism en-
zyme deﬁciencies. It is puzzling that some key enzymes
regulating intracellular ceramide levels have remained
elusive (Hannun andObeid 2002)—for example, the ﬁrst
ceramide kinase to be characterized was reported only
recently (Sugiura et al. 2002). However, despite the short
lapse of time, data on the function of ceramide-1-phos-
phate and ceramide kinase in several scenarios have
increased, stressing the roles of the relative levels of
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ceramide and ceramide-1-phosphate as intracellular in-
dicators for cell death/survival decisions (Frago et al.
2003) and adding a prominent role in the regulation/
modulation of inﬂammatory responses (Pettus et al.
2003).
Photoreceptor neurodegeneration in RP has been re-
ported to proceed by apoptosis triggered by cellular
stress. However, none of the described genetic defects
underlying inherited retinal dystrophies has provided a
direct link to apoptosis. It is interesting that a very re-
cent report showed that a decrease of the intracellular
ceramide pools rescued photoreceptor degeneration in
Drosophila mutants (Acharya et al. 2003). Ceramide
may be produced in the photoreceptors in response to
stress. In this case, deﬁciency of CERKL, a speciﬁc ret-
inal ceramide kinase, would increase the ceramide pool
or decrease the ceramide-1-phosphate levels, rendering
the photoreceptor cells more susceptible to stress and,
thus, more sensitive to apoptotic signals. The cumula-
tive effects of this enhanced susceptibility could lead to
progressive depletion of photoreceptors and, eventually,
to blindness. Failure to process the ceramide to cer-
amide-1-phosphate may trigger cell death not only by
increasing the endogenous ceramide pool but also by
failing to activate the corresponding downstream sig-
nalling pathway. Whether CERKL is transcriptionally
modulated in response to cellular stress stimuli remains
an open question.
This study—to our knowledge, the ﬁrst genetic report
linking RP to ceramide-induced apoptosis—highlights
the SL metabolism enzymes as new functional candi-
dates and establishes novel targets for therapeutic in-
tervention of retinal diseases.
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